CHD price target lowered

What happened: On April 7, UBS lowered its price target for Church & Dwight (CHD) to $98 from $102, maintaining a 'Neutral' rating. A week later, on April 14, Barclays and Bank of America both trimmed their price targets for Colgate-Palmolive (CL), with Barclays reducing its target to $79 from $88, while keeping an 'Equal Weight' rating.

Market impact: These target reductions reflect analysts' cautious outlook on consumer staples, specifically in the oral care and household products sectors. Both CHD and CL are prominent players in these segments, with CHD valued at $22.9 billion and CL at $58.7 billion by market cap. The lower targets suggest potential downward revisions in investor expectations for these companies' stock prices.

What to watch next: Investors should closely monitor CHD's Q1 earnings report, expected on April 28, for insights into its performance in the household and personal care categories. Additionally, CL's Q1 earnings, due on April 27, will provide updates on its oral care and personal care divisions. These earnings could either validate or challenge the analysts' bearish stance, driving the narrative's next evolution.